AI-generated summary
This review article describes current melasma treatments and the rationale for combining low-fluence Q-switched Nd:YAG laser therapy with other approaches. The authors report that this laser can selectively target dermal melanosomes without causing inflammation or epidermal damage in all skin phototypes, and that recent results have been promising. The abstract does not provide quantitative outcome data, so the strength of the evidence is unclear.
- Who or what was studied
- Individuals with melasma, a pigmentation disorder that commonly affects women with skin phototypes III-V
- Limits stated in the abstract
- The abstract is a narrative review without stated sample sizes or quantitative clinical results, so the reported promise of the laser cannot be quantified from the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scmsjournal.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Fluence, Inflammation, Melanin, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.